Management of epilepsy during pregnancy: An update

Therapeutic Advances in Neurological Disorders

Volumn 9, Issue 2, 2016, Pages 118-129

  Patel, Sima I ^a   Pennell, Page B ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

antiepileptic drugs; breast feeding; epilepsy; neurocognitive development; perinatal outcomes; pregnancy; seizures; teratogenicity

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; CLONAZEPAM; ETIRACETAM; FOLIC ACID; GABAPENTIN; GLUCURONOSYLTRANSFERASE 1A4; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ARTICLE; BREAST FEEDING; COGNITIVE DEVELOPMENT; DISEASE REGISTRY; DRUG BLOOD LEVEL; DRUG MONITORING; EPILEPSY; FOLIC ACID DEFICIENCY; GENETIC VARIABILITY; HUMAN; LOW BIRTH WEIGHT; MATERNAL CARE; MATERNAL HYPERTENSION; NEURAL TUBE DEFECT; PATIENT CARE; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK FACTOR; SEIZURE; TREATMENT OUTCOME; VAGINA BLEEDING;

EID: 84959932988     PISSN: 17562856     EISSN: 17562864     Source Type: Journal    
DOI: 10.1177/1756285615623934     Document Type: Article

References (46)

1. Artama M., Gissler M., Malm H., Ritvanen A., and the Drug & Pregnancy Group (2013) Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland. Drug Saf 36: 359-369.
2. Battino D., Tomson T., Bonizzoni E., Craig J., Lindhout D., Sabers A., et al. (2013) Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry. Epilepsia 54: 1621-1627.
3. Betts T., Fox C., (1999) Proactive pre-conception counselling for women with epilepsy-is it effective? Seizure 8: 322-327.
4. Bialer M., Johannessen S., Kupferberg H., Levy R., Perucca E., Tomson T., (2007) Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII). Epilepsy Res 73: 1-52.
5. Borthen I., Eide M., Veiby G., Daltveit A., Gilhus N., (2009) Complications during pregnancy in women with epilepsy: population-based cohort study. BJOG 116: 1736-1742.
6. Bromley R., Mawer G., Briggs M., Cheyne C., Clayton-Smith J., Garcia-Finana M., et al. (2013) The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 84: 637-43.
7. Campbell E., Kennedy F., Russell A., Smithson W., Parsons L., Morrison P., et al. (2014) Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. J Neurol Neurosurg Psychiatry 85: 1029-1034.
8. Chatzi L., Papadopoulou E., Koutra K., Roumeliotaki T., Georgiou V., Stratakis N., et al. (2012) Effect of high doses of folic acid supplementation in early pregnancy on child neurodevelopment at 18 months of age: the mother-child cohort 'Rhea' study in Crete, Greece. Public Health Nutr 15: 1728-1736.
9. EURAP (2006) Seizure control and treatment in pregnancy: observations from the EURAP Epilepsy Pregnancy Registry. Neurology 66: 354-360.
10. Harden C., Meador K., Pennell P., Hauser W., Gronseth G., French J., et al. (2009a) Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 50: 1237-1246.
11. Harden C., Pennell P., Koppel B., Hovinga C., Gidal B., Meador K., et al. (2009b) Management issues for women with epilepsy-focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 50: 1247-1255.
12. Hernandez-Diaz S., Smith C., Shen A., Mittendorf R., Hauser W., Yerby M., et al. (2012) Comparative safety of antiepileptic drugs during pregnancy. Neurology 78: 1692-1699.
13. Holmes L., Mittendorf R., Shen A., Smith C., Hernandez-Diaz S., (2011) Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Arch Neurol 68: 1275-1281.
14. Johnson E., Stowe Z., Ritchie J., Newport D., Newman M., Knight B., et al. (2014) Carbamazepine clearance and seizure stability during pregnancy. Epilepsy Behav 33: 49-53.
15. Kaaja E., Kaaja R., Hiilesmaa V., (2003) Major malformations in offspring of women with epilepsy. Neurology 60: 575-579.
16. Kaaja E., Kaaja R., Matila R., Hiilesmaa V., (2002) Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology 58: 549-553.
17. Kilic D., Pedersen H., Kjaersgaard M., Parner E., Vestergaard M., Sorensen M., et al. (2014) Birth outcomes after prenatal exposure to antiepileptic drugs-a population-based study. Epilepsia 55: 1714-1721.
18. Leppik I., Rask C., (1988) Pharmacokinetics of antiepileptic drugs during pregnancy. Semin Neurol 8: 240-246.
19. MacDonald S., Bateman B., McElrath T., Hernandez-Diaz S., (2015). Mortality and morbidity during delivery hospitalization among pregnant women with epilepsy in the United States. JAMA Neurol 72: 981-988.
20. Mawhinney E., Craig J., Morrow J., Russell A., Smithson W., Parsons L., et al. (2013) Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers. Neurology 80: 400-405.
21. McAuley J., Anderson G., (2002) Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations. Clin Pharmacokinet 41: 559-579.
22. Meador K., (2014) Breastfeeding and antiepileptic drugs. JAMA 311: 1797-1798.
23. Meador K., Baker G., Browning N., Clayton-Smith J., Combs-Cantrell D., Cohen M., et al. (2010) Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology 75: 1954-1960.
24. Meador K., Baker G., Browning N., Cohen M., Bromley R., Clayton-Smith J., et al. (2013) Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol 12: 244-252.
25. Morrow J., Russell A., Guthrie E., Parsons L., Robertson I., Waddell R., et al. (2006) Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77: 193-198.
26. Patsalos P., Bourgeois B., Cloyd J., Glauser T., Johannessen S., Leppik I., et al. (2008) Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the Subcommission on Therapeutic Drug Monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 49: 1239-1276.
27. Pennell P., PENG L., NEWPORT D., RITCHIE J., Koganti A., Holley D., et al. (2008) Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology 70: 2130-2136.
28. Pennell P., Klein A., Browning N., Baker G., Clayton-Smith J., Kalayjian L., et al. (2012) Differential effects of antiepileptic drugs on neonatal outcomes. Epilepsy Behav 24: 449-46.
29. Pennell P., Peng L., Newport D., Ritchie J., Koganti A., Holley D., et al. (2008) Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology 70: 2130-2136.
30. Petrenaite V., Sabers A., Hansen-Schwartz J., (2009) Seizure deterioration in women treated with oxcarbazepine during pregnancy. Epilepsy Res 84: 245-249.
31. Polepally A., Pennell P., Brundage R., Stowe Z., Newport D., Viguera A., et al. (2014) Model-based lamotrigine clearance changes during pregnancy: clinical implication. Ann Clin Transl Neurol 2: 99-106.
32. Rauchenzauner M., Ehrensberge M., Prieschl M., Kapelari K., Bergmann M., Walser G., et al. (2013) Generalized tonic-clonic seizures and antiepileptic drugs during pregnancy-a matter of importance for the baby? J Neurol 260: 484-488.
33. Reisinger T., Newman M., Loring D., Pennell P., Meador K., (2013) Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Epilepsy Behav 29: 13-18.
34. Roth C., Magnus P., Schjolberg S., Stoltenberg C., Suren P., McKeague I., et al. (2011) Folic acid supplements in pregnancy and severe language delay in children. JAMA 306: 1566-1573.
35. Tomson T., (2012) Teratogenic effects of antiepileptic drugs. Lancet Neurol 11: 803-813.
36. Tomson T., Battino D., (2007) Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium. Clin Pharmacokinet 46: 209-219.
37. Tomson T., Bonizzoni E., Craig J., Lindhout D., Sabers A., Perucca A., et al. (2011) Dose-dependent risk of malformations with antiepilepticdrugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 10: 609-616.
38. Tomson T., Lindbom U., Ekqvist B., Sundqvist A., (1994) Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin. Epilepsia 35, 122-130.
39. Tran T., Leppik I., Blesi K., Sathanandan S., Remmel R., (2002) Lamotrigine clearance during pregnancy. Neurology 59: 251-255.
40. Veiby G., Engelsen B., Gilhus N., (2013) Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy. JAMA Neurol 70: 1367-1374.
41. Viinikainen K., Heinonen S., Eriksson K., Kalviainen R., (2006) Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia 47: 186-192.
42. Wood A., Nadebaum C., Anderson V., Reutens D., Barton S., O'Brien T., et al. (2015) Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy. Epilepsia 56: 1047-1055.
43. Yerby M., (2000) Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Neurology 55: S21-S31; discussion S54-S58.
44. Yerby M., (2003) Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation. Epilepsia 44 (Suppl. 3): 33-40.
45. Yerby M., Friel P., McCormick K., (1992) Antiepileptic drug disposition during pregnancy. Neurology 42: 12-16.
46. Zhao Y., Hebert M., Venkataramanan R., (2014) Basic obstetric pharmacology. Semin Perinatol 38: 475-486.